Beijing Tong Ren Tang Chinese Medicine Co., Ltd. engages in the manufacture, retail and wholesale of Chinese medicine and healthcare products. The company employs 789 full-time employees The company went IPO on 2013-05-07. The firm operates its business through three segments. The Hong Kong segment engages in the sale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments through retail outlets as well as wholesale of Chinese medicine products in Hong Kong. The company is also involved in the royalty fee income from overseas entities using the brand of Tong Ren Tang. The Mainland China segment engages in the wholesale of healthcare products in Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments in other overseas countries.
Qui est le CEO de Beijing Tong Ren Tang Chinese Medicine Company Limited ?
Mr. Chi Wang est le Chief Executive Officer de Beijing Tong Ren Tang Chinese Medicine Company Limited, il a rejoint l'entreprise depuis 2024.
Quelle est la performance du prix de l'action BEIJING TONG REN TANG CHINESE M ?
Le prix actuel de BEIJING TONG REN TANG CHINESE M est de $0.6484, il a diminué de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Beijing Tong Ren Tang Chinese Medicine Company Limited ?
Beijing Tong Ren Tang Chinese Medicine Company Limited appartient à l'industrie Pharmaceuticals et le secteur est Health Care
Quel est la capitalisation boursière de Beijing Tong Ren Tang Chinese Medicine Company Limited ?
La capitalisation boursière actuelle de Beijing Tong Ren Tang Chinese Medicine Company Limited est de $542.7M
Est-ce que Beijing Tong Ren Tang Chinese Medicine Company Limited est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 4 analystes ont établi des notations d'analystes pour Beijing Tong Ren Tang Chinese Medicine Company Limited, y compris 2 achat fort, 5 achat, 1 maintien, 0 vente et 2 vente forte